Surmodics, Inc. (NASDAQ: SRDX) had its price target lowered by analysts at Needham & Company LLC from $47.00 to $43.00. They now have a "buy" rating on the stock.
SurModics (SRDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance [Yahoo! Finance]
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Surmodics, Inc. (NASDAQ: SRDX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.